Atrial fibrillation (AF) and atrial tachycardia (AT) are frequently observed in patients with chronic thromboembolic pulmonary hypertension (CTEPH) who were treated with pulmonary endarterectomy (PEA). Their prevalence and impact on prognosis of patients are not known. We analysed the prevalence of AF/AT and the clinical outcome in 197 patients with CTEPH treated with PEA (median age 62; interquartile range 53-68 years; 62% males). The prevalence of AF/AT was 29% (57 patients). Compared to patients without arrhythmia, the subjects with AF/AT were older [60 (50-67) vs. 62 (57-70) years], manifested an increased size of the left atrium [39 (35-44) vs. 45 (40-50) mm], had a reduced 6-min walking distance [411 (321-506) vs. 340 (254-460) m], and higher pulmonary artery systolic pressure after PEA [38 (30-47) vs. 45 (38-71) mmHg], all results with P-value <0.05. During the follow-up with a median 4.2 (1.6-6.3) years, 45 (23%) patients died. In a multivariate Cox regression model only the male gender [hazard ratio (HR) 2.27, 95% confidence interval (CI) 1.15-4.50], a reduced 6-min walking distance (HR 3.67, 95% CI 1.74-7.73), and an increased New York Heart Association class (HR 8.56, 95% CI 4.17-17.60) were associated with mortality (P < 0.05). The prevalence of AF/AT in patients with CTEPH treated with PEA is high. Arrhythmias are associated with reduced functional capacity but not with mortality.

2nd Department of Medicine Department of Cardiovascular Medicine General University Hospital Prague 1st Faculty of Medicine Charles University U Nemocnice 2 Prague 128 08 Czech Republic

2nd Department of Surgery Department of Cardiovascular Surgery General Univesity Hospital Prague 1st Faculty of Medicine Charles University U Nemocnice 2 Prague 128 08 Czech Republic

Department of Anesthesiology Resuscitation and Intensive Medicine General Univesity Hospital Prague 1st Faculty of Medicine Charles University U Nemocnice 2 Prague 128 08 Czech Republic

Regional Hospital in Tabor Kpt Jarose 2000 Tabor 390 03 Czech Republic

See more in PubMed

Galiè N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016;37:67–119. PubMed

Konstantinides SV, Meyer G.. The 2019 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2019;40:3453–3455. PubMed

Amsallem M, Guihaire J, Arthur Ataam J, Lamrani L, Boulate D, Mussot S, Fabre D, Taniguchi Y, Haddad F, Sitbon O, Jais X, Humbert M, Simonneau G, Mercier O, Brenot P, Fadel E.. Impact of the initiation of balloon pulmonary angioplasty program on referral of patients with chronic thromboembolic pulmonary hypertension to surgery. J Heart Lung Transplant 2018;37:1102–1110. PubMed

Lang IM, Madani M.. Update on chronic thromboembolic pulmonary hypertension. Circulation 2014;130:508–518. PubMed

Delcroix M, Lang I, Pepke-Zaba J, Jansa P, D’Armini AM, Snijder R, Bresser P, Torbicki A, Mellemkjaer S, Lewczuk J, Simkova I, Barberà JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Jaïs X, Ambroz D, Treacy C, Morsolini M, Jenkins D, Lindner J, Dartevelle P, Mayer E, Simonneau G.. Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an International Prospective Registry. Circulation 2016;133:859–871. PubMed

Daliento L, Somerville J, Presbitero P, Menti L, Brach-Prever S, Rizzoli G, Stone S.. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J 1998;19:1845–1855. PubMed

Olsson KM, Nickel NP, Tongers J, Hoeper MM.. Atrial flutter and fibrillation in patients with pulmonary hypertension. Int J Cardiol 2013;167:2300–2305. PubMed

Rottlaender D, Motloch LJ, Schmidt D, Reda S, Larbig R, Wolny M, Dumitrescu D, Rosenkranz S, Erdmann E, Hoppe UC.. Clinical impact of atrial fibrillation in patients with pulmonary hypertension. PLoS One 2012;7:e33902. PubMed PMC

Ruiz-Cano MJ, Gonzalez-Mansilla A, Escribano P, Delgado J, Arribas F, Torres J, Flox A, Riva M, Gomez MA, Saenz C.. Clinical implications of supraventricular arrhythmias in patients with severe pulmonary arterial hypertension. Int J Cardiol 2011;146:105–106. PubMed

Tongers J, Schwerdtfeger B, Klein G, Kempf T, Schaefer A, Knapp J-M, Niehaus M, Korte T, Hoeper MM.. Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. Am Heart J 2007;153:127–132. PubMed

Wen L, Sun M-L, An P, Jiang X, Sun K, Zheng L, Liu Q-Q, Wang L, Zhao Q-H, He J, Jing Z-C.. Frequency of supraventricular arrhythmias in patients with idiopathic pulmonary arterial hypertension. Am J Cardiol 2014;114:1420–1425. PubMed

Fingrova Z, Havranek S, Ambroz D, Jansa P, Linhart A.. The left atrial substrate plays a significant role in the development of complex atrial tachycardia in patients with precapillary pulmonary hypertension. BMC Cardiovasc Disord 2019;19:157. PubMed PMC

Daily PO, Dembitsky WP, Peterson KL, Moser KM.. Modifications of techniques and early results of pulmonary thromboendarterectomy for chronic pulmonary embolism. J Thorac Cardiovasc Surg 1987;93:221–233. PubMed

Jamieson SW, Kapelanski DP.. Pulmonary endarterectomy. Curr Probl Surg 2000;37:165–252. PubMed

Lindner J, Jansa P, Kunstyr J, Mayer E, Blaha J, Palecek T, Aschermann M, Grus T, Ambroz D, Tosovský J, Vitkova I.. Implementation of a new programme for the surgical treatment of CTEPH in the Czech Republic—pulmonary endarterectomy. Thorac Cardiovasc Surg 2006;54:528–531. PubMed

Cannillo M, Grosso Marra W, Gili S, D'Ascenzo F, Morello M, Mercante L, Mistretta E, Salera D, Zema D, Bissolino A, Fusaro E, Marra S, Libertucci D, Gaita F.. Supraventricular arrhythmias in patients with pulmonary arterial hypertension. Am J Cardiol 2015;116:1883–1889. PubMed

Pietra GG, Capron F, Stewart S, Leone O, Humbert M, Robbins IM, Reid LM, Tuder RM.. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 2004;43(12 Suppl S):25S–32S. PubMed

Medi C, Kalman JM, Ling L-H, Teh AW, Lee G, Lee G, Spence SJ, Kaye DM, Kistler PM.. Atrial electrical and structural remodeling associated with longstanding pulmonary hypertension and right ventricular hypertrophy in humans. J Cardiovasc Electr 2012;23:614–620. PubMed

Folino AF, Bobbo F, Schiraldi C, Tona F, Romano S, Buja G, Bellotto F.. Ventricular arrhythmias and autonomic profile in patients with primary pulmonary hypertension. Lung 2003;181:321–328. PubMed

Schrier RW, Bansal S.. Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure? Clin J Am Soc Nephrol 2008;3:1232–1237. PubMed PMC

Borlaug BA, Nishimura RA, Sorajja P, Lam CS, Redfield MM.. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 2010;3:588–595. PubMed PMC

D'Alto M, Romeo E, Argiento P, Motoji Y, Correra A, Di Marco GM, Iacono AM, Barracano R, D'Andrea A, Rea G, Sarubbi B, Russo MG, Naeije R.. Clinical relevance of fluid challenge in patients evaluated for pulmonary hypertension. Chest 2017;151:119–126. PubMed

Nguyen BL, Fishbein MC, Chen LS, Chen PS, Masroor S.. Histopathological substrate for chronic atrial fibrillation in humans. Heart Rhythm 2009;6:454–460. PubMed PMC

Chimenti C, Russo MA, Carpi A, Frustaci A.. Histological substrate of human atrial fibrillation. Biomed Pharmacother 2010;64:177–183. PubMed

Arsenault KA, Yusuf AM, Crystal E, Healey JS, Morillo CA, Nair GM, Whitlock RP.. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev 2013;1:CD003611. PubMed PMC

Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, Barash PG, Hsu PH, Mangano DT; Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004;291:1720–1729. PubMed

Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ní Áinle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020;41:543–603. PubMed

Catheter ablation of atrial fibrillation and atrial tachycardia in patients with pulmonary hypertension: a randomized study

The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension